Pulse Biosciences

Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed-Field Ablation or nsPFA technology when used to ablate cellular tissue, can be used to treat a variety of medical conditions for which an optimal solution remains unfulfilled.

Movers

News

Intraday Update

Markets

Trading Ideas

AILE

ASND

CLNE

CLVT

CVNA

DELL

ELAN

HSAI

LOAR

NVDA

NYCB

PACS

PLSE

SBUX

SMCI

SMTC

SPRY

UPST

Loar Holdings Posts Upbeat Results, Joins Nvidia, Clean Energy Fuels, Penumbra And Other Big Stocks Moving Higher On Tuesday

Russell,2000,Index.magnifying,Glass,Showing,The,Words.background,Of,Banknotes,And

Analyst Color

Broad U.S. Equity ETFs

Small Cap

ETFs

EVGO

IGMS

LNTH

MORF

OUST

SOUN

The Russell 2000 index of small caps recorded its best weekly performance since October 2023, surging over 6%, driven by lower-than-expected June inflation data and potential interest rate cuts.

Russell 2000 Index Notches Strongest Week Of Year, Hits 31-Month Highs: Outlook Is &#39;Clouded By Fed&#39;s Concerns Over Labor Market,&#39; Analyst Warns

ARHS

BENF

CJET

CLDI

CLEU

DYNT

GRFS

HLVX

IDYA

INTC

IONM

JEWL

KOSS

Maxeon Solar Technologies, Ltd. - Ordinary Shares

MAXN

MYNZ

NEGG

NKLA

OPTT

PARAA

Qualigen Therapeutics, Inc. - Common Stock

QLGN

RYDE

SEDG

SHPW

SIRI

SLRN

SVMH

UXIN

VIVK

VRPX

WETH

ZAPP

Why Arhaus Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Monday&#39;s Mid-Day Session

Pulse Biosciences Inc

Press Releases

Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Pulse Biosciences Schedules Fourth Quarter & Full Year 2024 Financial Results Conference Call for March 27, 2025

Pulse Biosciences To Present at the 24th Annual Needham Virtual Health Care Conference

Pulse Biosciences Reports Business Updates and Fourth Quarter & Full Year 2024 Financial Results

Pulse Biosciences' Nanosecond PFA Technology to be Featured at The Heart Rhythm Society 2025 Annual Meeting

Pulse Biosciences Schedules First Quarter 2025 Financial Results Conference Call for May 8, 2025

Pulse Biosciences' Nanosecond PFA Technology to be Featured at The American Association for Thoracic Surgery 2025 Annual Meeting

Pulse Biosciences To Present at the BofA Securities 2025 Health Care Conference

Pulse Biosciences Reports Business Updates and First Quarter 2025 Financial Results

AngioDynamics

Artivion

Alphatec Holdings

AtriCure

Axogen

Beta Bionics

Butterfly Network, Inc. Class A Common Stock

Butterfly Network

CeriBell

Conmed

Delcath Systems

Enovis

Integra LifeSciences Holdings Corporation - Common Stock

Integra Lifesciences

iRadimed

Kestra Medical Technologies, Ltd. - Common Stock

Kestra Medical Techs

LeMaitre Vascular

NeuroPace

NovoCure

Orthofix Medical

Omnicell

QuidelOrtho

SI-BONE

Surmodics

SS Innovations International Inc. - Common Stock

SS Innovations

Treace Medical Concepts, Inc. - Common Stock

Treace Medical Concepts

Tandem Diabetes Care, Inc. - Common Stock

Tandem Diabetes Care

Comments

Pulse Biosciences

Connect With Us

About Benzinga

Market Resources

Trading Tools & Education

Ring the Bell